Axsome Therapeutics Quarterly Balance Sheets Chart
Quarterly
|
Annual
Axsome Therapeutics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 303,016,000 | 300,910,000 | 315,353,000 | 327,341,000 | 315,657,000 | 331,441,000 | 386,193,000 | 416,564,000 | 437,113,000 | 246,515,000 | 200,841,955 | 227,520,218 | 73,394,640 | 84,707,782 | 86,472,854 | 114,622,893 | 141,219,090 | 164,660,132 | 183,876,453 | 202,360,292 | 190,682,109 | 197,313,408 | 43,641,861 | 53,753,137 | 42,624,487 | ||||||||||||||
| accounts receivable | 198,825,000 | 161,398,000 | 142,001,000 | ||||||||||||||||||||||||||||||||||||
| inventories | 18,441,000 | 16,319,000 | 15,732,000 | 14,265,000 | 15,220,000 | 15,583,000 | 15,135,000 | 9,985,000 | 9,252,000 | 7,940,000 | 4,319,921 | 2,103,477 | 10,323,746 | ||||||||||||||||||||||||||
| prepaid and other current assets | 16,338,000 | 16,007,000 | 11,978,000 | 13,411,000 | 11,808,000 | 12,032,000 | 8,115,000 | 6,799,000 | 5,911,000 | 5,201,000 | 2,780,665 | 2,457,513 | 4,091,369 | 2,122,144 | 45,286 | 401,302 | 435,804 | 375,306 | 148,373 | 911,992 | 137,181 | 309,370 | 413,095 | 594,345 | 814,913 | 1,134,692 | 1,246,360 | 723,669 | 1,187,961 | 1,121,003 | 746,094 | 842,597 | 1,179,124 | 867,099 | 1,164,873 | 987,552 | 996,618 | ||
| total current assets | 536,620,000 | 494,634,000 | 485,064,000 | 479,113,000 | 463,027,000 | 460,490,000 | 504,263,000 | 511,763,000 | 519,686,000 | 304,449,000 | 245,641,409 | 252,383,430 | 103,977,682 | 86,829,926 | 86,518,140 | 115,024,195 | 141,654,894 | 165,035,438 | 184,024,826 | 203,272,284 | 190,819,290 | 197,622,778 | 220,379,262 | 44,236,206 | 54,568,050 | 43,759,179 | 15,215,102 | 15,944,433 | 21,539,404 | 27,753,698 | 32,419,477 | 38,837,046 | 46,198,751 | 34,754,903 | 39,916,623 | 45,065,552 | 49,032,878 | ||
| equipment | 667,000 | 773,000 | 584,000 | 683,000 | 724,000 | 812,000 | 846,000 | 971,000 | 736,000 | 703,000 | 722,515 | 626,990 | 634,611 | 460,946 | 283,846 | 314,891 | 83,444 | 74,316 | 52,647 | 39,745 | 30,422 | 34,518 | 30,623 | 34,554 | 40,747 | 40,393 | 51,832 | 64,039 | 68,635 | 70,709 | 79,344 | 86,524 | 93,516 | 104,426 | 33,790 | 25,192 | 16,653 | ||
| right-of-use asset - operating lease | 22,472,000 | 23,294,000 | 5,383,000 | 5,730,000 | 6,071,000 | 6,411,000 | 6,772,000 | 7,068,000 | 7,412,000 | 106,000 | 420,298 | 384,568 | 667,582 | 946,479 | 660,162 | 936,526 | 1,209,037 | 1,476,711 | 1,739,475 | ||||||||||||||||||||
| goodwill | 12,042,000 | 12,042,000 | 12,042,000 | 12,042,000 | 12,042,000 | 12,042,000 | 12,042,000 | 12,042,000 | 12,042,000 | 10,310,000 | 10,310,000 | 11,897,000 | 11,897,407 | ||||||||||||||||||||||||||
| intangible asset | 43,733,000 | 45,322,000 | 46,894,000 | 48,501,000 | 50,107,000 | 51,697,000 | 53,286,000 | 54,893,000 | 56,500,000 | 58,089,000 | 59,660,772 | 61,267,561 | 62,874,350 | ||||||||||||||||||||||||||
| non-current inventory and other assets | 24,251,000 | 20,606,000 | 18,531,000 | 15,389,000 | 16,255,000 | 14,276,000 | 11,027,000 | 14,120,000 | 15,262,000 | 15,522,000 | 14,721,101 | 12,398,220 | |||||||||||||||||||||||||||
| total assets | 639,785,000 | 596,671,000 | 568,498,000 | 561,458,000 | 548,226,000 | 545,728,000 | 588,236,000 | 600,857,000 | 611,638,000 | 389,179,000 | 331,476,095 | 338,957,769 | 180,559,096 | 88,560,261 | 87,785,058 | 116,598,522 | 143,264,750 | 166,903,840 | 186,134,323 | 203,629,404 | 190,989,587 | 197,800,871 | 220,549,760 | 44,439,729 | 54,777,766 | 43,901,088 | 15,379,279 | 16,125,828 | 21,725,395 | 27,939,296 | 35,555,564 | 32,618,112 | 39,042,861 | 46,411,558 | 38,212,608 | 34,918,454 | 40,007,913 | 45,148,244 | 49,076,156 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||
| accounts payable | 91,628,000 | 85,659,000 | 71,997,000 | 64,253,000 | 61,340,000 | 53,791,000 | 40,679,000 | 29,098,000 | 42,958,000 | 35,770,000 | 38,605,312 | 12,844,629 | 19,430,961 | 12,595,112 | 13,149,329 | 13,381,681 | 11,611,996 | 14,621,717 | 13,504,022 | 11,315,126 | 9,363,225 | 12,191,714 | 10,943,325 | 9,447,359 | 6,137,120 | 3,434,184 | 3,687,245 | 4,167,369 | 3,175,178 | 3,874,592 | 2,942,999 | 4,038,645 | 4,740,702 | 3,867,584 | 3,035,038 | 1,830,422 | 1,892,363 | ||
| accrued expenses and other current liabilities | 170,902,000 | 149,199,000 | 147,987,000 | 122,176,000 | 116,771,000 | 82,716,000 | 90,501,000 | 78,454,000 | 65,324,000 | 58,774,000 | 51,630,813 | 40,021,759 | 16,480,322 | 10,987,222 | 9,295,180 | 10,445,172 | 10,162,831 | 5,864,526 | 8,713,249 | 9,026,412 | 7,091,470 | 9,339,721 | 10,949,128 | 8,413,107 | 4,777,958 | 3,739,846 | 3,843,299 | 3,387,771 | 2,953,631 | 2,153,051 | 2,743,575 | 2,276,750 | 2,535,124 | ||||||
| operating lease liability, current portion | 337,000 | 454,000 | 1,835,000 | 1,627,000 | 1,419,000 | 1,153,000 | 1,267,000 | 438,000 | 350,000 | 108,000 | 424,673 | 416,876 | 709,120 | 967,248 | 620,675 | 880,116 | 1,088,841 | 1,196,539 | 1,220,587 | ||||||||||||||||||||
| contingent consideration, current | 9,232,000 | 8,602,000 | 8,285,000 | 8,131,000 | 7,040,000 | 6,388,000 | 6,407,000 | 6,672,000 | 6,342,000 | 6,000,000 | 5,900,000 | 7,000,000 | 5,950,000 | ||||||||||||||||||||||||||
| short-term borrowings | 70,000,000 | ||||||||||||||||||||||||||||||||||||||
| total current liabilities | 342,099,000 | 243,914,000 | 230,104,000 | 196,187,000 | 186,570,000 | 144,048,000 | 138,854,000 | 114,662,000 | 114,974,000 | 100,652,000 | 96,560,798 | 60,283,264 | 42,570,403 | 24,549,582 | 23,065,184 | 24,706,969 | 22,863,668 | 21,682,782 | 23,437,858 | 20,341,538 | 23,001,956 | 26,099,867 | 24,494,745 | 18,508,989 | 13,070,100 | 7,709,797 | 10,821,938 | 10,942,696 | 9,525,984 | 9,420,951 | 12,175,336 | 8,403,616 | 8,211,190 | 8,355,750 | 7,170,712 | 6,735,536 | 5,103,558 | 3,913,732 | 2,631,895 |
| contingent consideration, non-current | 79,655,000 | 90,590,000 | 91,680,000 | 82,980,000 | 69,620,000 | 70,000,000 | 73,300,000 | 31,550,000 | 33,500,000 | 29,100,000 | 31,100,000 | 27,400,000 | 29,330,407 | ||||||||||||||||||||||||||
| loan payable, long-term | 117,540,000 | 181,377,000 | 180,710,000 | 180,002,000 | 179,330,000 | 178,689,000 | 178,070,000 | 177,446,000 | 176,820,000 | 147,615,000 | 94,258,888 | 93,913,159 | 93,458,824 | 49,312,665 | 49,089,522 | 49,173,709 | 48,882,599 | 48,597,943 | 48,321,848 | 15,544,138 | 17,332,626 | 19,108,144 | 17,424,721 | 18,817,592 | 3,619,420 | 4,440,375 | 5,190,512 | 5,932,191 | 7,375,439 | 8,077,063 | 8,775,328 | ||||||||
| operating lease liability, long-term | 23,624,000 | 23,905,000 | 6,046,000 | 6,440,000 | 6,829,000 | 7,258,000 | 7,035,000 | 7,691,000 | 7,540,000 | 81,863 | 329,916 | 581,708 | |||||||||||||||||||||||||||
| finance lease liability, long-term | 3,792,000 | 3,680,000 | 2,943,000 | 2,951,000 | 3,025,000 | 1,697,000 | |||||||||||||||||||||||||||||||||
| total liabilities | 566,710,000 | 543,466,000 | 511,483,000 | 468,560,000 | 445,374,000 | 401,692,000 | 397,259,000 | 331,349,000 | 332,834,000 | 277,367,000 | 221,919,686 | 181,596,423 | 165,359,634 | 73,862,247 | 72,154,706 | 73,880,678 | 71,828,130 | 70,610,641 | 72,341,414 | 41,644,005 | 41,827,371 | 37,617,133 | 30,494,821 | 26,527,389 | 14,441,358 | 15,383,071 | 14,716,496 | 15,353,142 | 15,779,055 | 16,288,253 | 17,131,078 | 2,631,895 | |||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share | |||||||||||||||||||||||||||||||||||||||
| common stock | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 4,000 | 4,350 | 4,342 | 3,991 | 3,888 | 3,782 | 3,769 | 3,765 | 3,756 | 3,737 | 3,733 | 3,726 | 3,707 | 3,693 | 3,450 | 3,433 | 3,330 | 3,009 | 2,683 | 2,625 | 2,555 | 2,367 | 2,361 | 2,354 | 1,915 | 1,915 | 1,915 | 1,915 | ||
| additional paid-in capital | 1,303,243,000 | 1,235,400,000 | 1,179,797,000 | 1,140,768,000 | 1,086,120,000 | 1,047,959,000 | 1,026,543,000 | 1,006,423,000 | 953,520,000 | 719,359,000 | 705,884,795 | 692,450,128 | 505,465,383 | 463,525,522 | 424,825,655 | 417,937,024 | 411,773,127 | 404,345,506 | 392,585,265 | 384,889,471 | 380,946,215 | 364,532,798 | 354,614,189 | 157,907,655 | 156,232,409 | 135,561,052 | 108,485,219 | 98,693,366 | 96,677,592 | 93,974,001 | 85,991,032 | 85,473,053 | 84,914,616 | 68,493,516 | 68,020,369 | 65,887,336 | 65,231,144 | ||
| accumulated deficit | -1,230,173,000 | -1,182,200,000 | -1,122,787,000 | -1,047,875,000 | -983,273,000 | -903,928,000 | -835,571,000 | -736,920,000 | -674,721,000 | -607,551,000 | -596,332,736 | -535,093,124 | -490,269,912 | -448,831,396 | -409,199,085 | -375,222,949 | -340,340,272 | -308,056,063 | -278,796,093 | -249,631,446 | -226,706,631 | -208,379,639 | -175,895,493 | -151,088,509 | -131,952,897 | -118,190,683 | -107,550,307 | -97,953,292 | -89,671,318 | -81,390,402 | -76,584,843 | -69,154,342 | -62,720,806 | -55,636,490 | -47,641,451 | -40,312,513 | -33,117,929 | -24,654,739 | -18,788,798 |
| total stockholders’ equity | 73,075,000 | 53,205,000 | 57,015,000 | 92,898,000 | 102,852,000 | 144,036,000 | 190,977,000 | 269,508,000 | 278,804,000 | 111,812,000 | 109,556,409 | 157,361,346 | 15,199,462 | 14,698,014 | 15,630,352 | 42,717,844 | 71,436,620 | 96,293,199 | 113,792,909 | 135,261,758 | 154,243,310 | 156,156,866 | 178,722,389 | 6,822,596 | 24,282,945 | 17,373,699 | 937,921 | 742,757 | 7,008,899 | 12,586,154 | 16,717,223 | 16,839,057 | 22,754,608 | 29,280,480 | 21,571,451 | 28,182,918 | 34,904,355 | 41,234,512 | 46,444,261 |
| total liabilities and stockholders’ equity | 639,785,000 | 596,671,000 | 568,498,000 | 561,458,000 | 548,226,000 | 545,728,000 | 588,236,000 | 600,857,000 | 611,638,000 | 389,179,000 | 331,476,095 | 338,957,769 | 180,559,096 | 88,560,261 | 87,785,058 | 116,598,522 | 143,264,750 | 166,903,840 | 186,134,323 | 203,629,404 | 190,989,587 | 197,800,871 | 220,549,760 | 44,439,729 | 54,777,766 | 43,901,088 | 15,379,279 | 16,125,828 | 21,725,395 | 27,939,296 | 32,618,112 | 39,042,861 | 46,411,558 | 34,918,454 | 40,007,913 | 45,148,244 | 49,076,156 | ||
| accounts receivables | 124,096,000 | 120,342,000 | 101,434,000 | 94,820,000 | 78,415,000 | 67,410,000 | 44,793,000 | 37,698,868 | 20,302,222 | 16,167,927 | |||||||||||||||||||||||||||||
| other assets | 507,464 | 322,910 | 322,910 | 322,910 | 317,375 | 317,375 | 317,375 | 317,375 | 139,875 | 143,575 | 139,875 | 168,969 | 168,969 | 101,516 | 112,345 | 117,356 | 117,356 | 114,889 | 119,291 | 119,291 | 119,291 | 59,125 | 57,500 | 57,500 | 26,625 | ||||||||||||||
| preferred stock, 0.0001 par value per share (10,000,000 shares authorized, none issued and outstanding at december 31, 2021 and december 31, 2020, respectively | |||||||||||||||||||||||||||||||||||||||
| loan payable, current portion | 4,568,432 | 2,602,292 | 648,523 | 2,155,022 | 535,767 | 3,291,394 | 3,285,556 | 3,280,175 | 3,275,308 | 2,717,042 | 1,895,795 | 1,079,924 | |||||||||||||||||||||||||||
| | |||||||||||||||||||||||||||||||||||||||
| cash | 219,966,167 | 13,968,742 | 15,220,764 | 20,351,443 | 26,632,695 | 34,021,123 | 31,673,383 | 37,994,449 | 45,019,627 | 36,618,497 | 33,887,804 | 38,751,750 | 44,078,000 | 48,036,260 | |||||||||||||||||||||||||
| warrant liability | 102,000 | 117,000 | 118,000 | ||||||||||||||||||||||||||||||||||||
| balance sheet data: | |||||||||||||||||||||||||||||||||||||||
| loan payable, long-term, net of discounts | 6,663,005 | 9,470,445 | |||||||||||||||||||||||||||||||||||||
| convertible notes, net of discounts, non-current portion | |||||||||||||||||||||||||||||||||||||||
| interest payable, non-current portion | |||||||||||||||||||||||||||||||||||||||
| embedded derivative liabilities | |||||||||||||||||||||||||||||||||||||||
| accrued expenses | 2,867,952 | 2,068,520 | 2,083,310 | 739,532 | |||||||||||||||||||||||||||||||||||
| deferred financing fees | |||||||||||||||||||||||||||||||||||||||
| loan from related party | |||||||||||||||||||||||||||||||||||||||
| stockholders’ equity |
We provide you with 20 years of balance sheets for Axsome Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Axsome Therapeutics. Explore the full financial landscape of Axsome Therapeutics stock with our expertly curated balance sheets.
The information provided in this report about Axsome Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.